SEC Form D private-offering filing

Solve Therapeutics, Inc.

Name: Solve Therapeutics, Inc. - new SEC Form D private-offering filing, Belmont, CA
Published: 2025-11-25

A new SEC Form D private-offering notice from Belmont, CA, a $120,535,618 filer-stated offering target in Biotech. The source filing is one click away.

Solve Therapeutics, Inc. site↗ Verified via SEC Form D

Develops antibody-drug conjugates and bispecific therapeutics for solid tumor oncology using proprietary linker technology.

Filed 2025-11-25Filed to raise $120,535,618First money in 2025-11-14Raised so far $48,214,232HQ (as filed) Belmont, CASector Biotech ✓Stage (inferred) LateCall status Call-ready

Source linked the Form D on EDGAR↗Website verified solvetx.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.